Literature DB >> 31712975

[New developments in topical pharmaceuticals].

Johannes Wohlrab1.   

Abstract

Topical preparations are by far the most frequently used therapeutic or prophylactic pharmaceuticals by dermatologists. Although only a few new active ingredients in topical pharmaceuticals have reached the market in recent years, some innovative galenic concepts and strategies considering the intrinsic effect of topical preparations have been developed, and it is quite certain that we can count on more genuine innovations in the near future. In particular small molecules, but also biological drugs, can be expected to be delivered by topical preparations, especially for inflammatory diseases. Also, we await innovative strategies for the substitution or regulation of the physicochemical and microbiological barrier function of the skin, including completely new options relating to the application of ribonucleic acid derivatives or their inhibitors aiming at influencing gene expression. Overall, it can be stated that the potential of epicutaneous application will take shape in modern vehicle strategies and procedures that deploy the intrinsic effect of topical preparations and that progress in biotechnology and physical chemistry will become increasingly relevant in practice.

Entities:  

Keywords:  Epicutaneous adminstration; Pharmaceutical vehicle strategies; Prophylaxis; Therapy; Topical drug administration

Mesh:

Substances:

Year:  2019        PMID: 31712975     DOI: 10.1007/s00105-019-04505-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  56 in total

1.  Local Immunomodulation Using an Adhesive Hydrogel Loaded with miRNA-Laden Nanoparticles Promotes Wound Healing.

Authors:  Bahram Saleh; Harkiranpreet Kaur Dhaliwal; Roberto Portillo-Lara; Ehsan Shirzaei Sani; Reza Abdi; Mansoor M Amiji; Nasim Annabi
Journal:  Small       Date:  2019-07-22       Impact factor: 13.281

2.  Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata.

Authors:  Cheryl B Bayart; Katherine L DeNiro; Lars Brichta; Brittany G Craiglow; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2017-07       Impact factor: 11.527

3.  Dermal peptide delivery using enhancer molecules and colloidal carrier systems. Part III: Tetrapeptide GEKG.

Authors:  Elfi Sommer; Reinhard H H Neubert; Matthias Mentel; Benjamin Tuchscherer; Yahja Mrestani; Johannes Wohlrab
Journal:  Eur J Pharm Sci       Date:  2018-08-27       Impact factor: 4.384

4.  [Basics of topical therapy].

Authors:  J Wohlrab
Journal:  Hautarzt       Date:  2014-03       Impact factor: 0.751

5.  Skin care products: What do they promise, what do they deliver.

Authors:  Christian Surber; Jan Kottner
Journal:  J Tissue Viability       Date:  2016-03-28       Impact factor: 2.932

6.  Penetration of heat and cold application through vital tissue.

Authors:  R L Cooley; S F Robison; W W Barkmeier
Journal:  Quintessence Int Dent Dig       Date:  1980-10

7.  Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis.

Authors:  Salih Levent Cinar; Demet Kartal; Ayşe Kacar Bayram; Mehmet Canpolat; Murat Borlu; Ayten Ferahbas; Hüseyin Per
Journal:  Indian J Dermatol Venereol Leprol       Date:  2017 Jan-Feb       Impact factor: 2.545

8.  The use of heat and chemical penetration enhancers to increase the follicular delivery of erythromycin to the skin.

Authors:  F Caserta; M B Brown; W J McAuley
Journal:  Eur J Pharm Sci       Date:  2019-02-21       Impact factor: 4.384

Review 9.  Potential Role of the Microbiome in Acne: A Comprehensive Review.

Authors:  Young Bok Lee; Eun Jung Byun; Hei Sung Kim
Journal:  J Clin Med       Date:  2019-07-07       Impact factor: 4.241

10.  A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.

Authors:  Dee Anna Glaser; Adelaide A Hebert; Alexander Nast; William P Werschler; Lawrence Green; Richard D Mamelok; John Quiring; Janice Drew; David M Pariser
Journal:  Am J Clin Dermatol       Date:  2019-08       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.